Síndromes mieloproliferativos monocelulares de protagonismo tisular. Histiocitosis y mastocitosis primarias como probables mielopatías monoclonales

Revista Clinica Espanola

Volumn 197, Issue 7, 1997, Pages 512-517

  Sanchez Fayos J ^a,b   Prieto Pareja, E ^a   Roman Barbero A ^a   Calabuig Fenollar, T ^a   Outeirino Hernanz J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Instituto Reina Sofía de Investigación Nefrológica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL; EOSINOPHILIA; HISTIOCYTOSIS; HUMAN; IMMUNOLOGY; MASTOCYTOSIS; MYELOPROLIFERATIVE DISORDER; REVIEW;

EOSINOPHILIA; EOSINOPHILS; HISTIOCYTOSIS; HUMANS; MASTOCYTOSIS; MYELOPROLIFERATIVE DISORDERS;

EID: 0031179843     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Dameshek W. Some especulations on the myeloproliferative syndromes Blood 1951, 6:372-375.
2. Sánchez Fayos J. Visión integrada de la patologia de la célula pluripotencial hemopoyética. Rev Clin Esp 1986; 178.347-353.
3. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HC. Bjorson BH. The idiopatic hypereosinophilic syndrome: clinical, pathophisiological and therapeutic considerations Ann Intern Med 1982; 97:78-92.
4. Da Silva MA, Heerema N, Cchwenk GR, Hoffman R Evidence for the clonal nature of the hypereosinophilic syndrome. Cancer Genetic and Cytogenetic 1988; 32 109-115.
5. Cassi E, De Paoli A, Favas S, Luoni M, Tosi A. Turri C, Grimi E, idiopathic hypereosinophilic syndrome and eosinophilic leukemia. Haematologica 1992; 77:430-432.
6. Kwong YL, Chen G. Clonal nature of chronic neutrophilic leukemia. Blood 1993; 82:1 035-1.038
7. Luppi M, Marassa R, Morselli M, Borozzi P, Torelli G. Clonal nature of hypereosinophilic syndrome. Blood 1994; 84:349-350.
8. Gastearena J, Orúe MT, Uriz MJ, Pérez E, Calavia J. Gorosquieta A. Leucemia neutrofilica crónica Sangre 1995; 40:499-503
9. Van Furth R. Current view on the mononuclear phagocytic system. Immunobiology 1982; 161:178-187
10. Lasser A. The mononuclear phagocytic system: a review. Human Pathol 1983; 14:108-126.
11. Johnston RB. Monocytes and macrophages. N Eng J Med 1988; 318:747-752
12. Liechtenstein L. Histiocitosis X: integration of eosinophilic granuloma of bone. Letterer-Siwe disease and Schuller-Christian disease as related manifestations of a single nosologic entity Arch Pathol 1953; 56:84-102.
13. Nezelof C, Basset F, Rousseau MF. Histiocytosis X: histogenesis arguments for a Langerhans cell origin. Biomedicine 1973; 18:365-371.
14. Komp DM. Langerhans cell histiocytosis. N Engl J Med 1987; 316:747-748.
15. Martinez González MA. Célula de Langerhans: origen y función. Patología 1987, 20:1-3.
16. Woessner S. Histiocitosis de células de Langerhans. Med Clin (Barc) 1989; 93:457-459.
17. Favara BE. Langerhans' cell histiocytosis: pathobiology and pathogenesis. Sem Oncol 1991; 18:3-7.
18. McClain K, Jin H, Gresik V, Favara B Langerhans cell histiocytosis; lack of a viral etiology.
19. Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer 1994; 70 (suppl XXII).S37-S40.
20. Rabkin MS, Wittwer CT, Kjeldsberg CR, Piepkorn MW. Flow cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis). Am J Pathol 1988; 131:283-289.
21. Lucas GS, Padua RA, Masters GS, Oscier DG, Jacob A. The applications of X-chromosome gene probes to the diagnosis of myeloproliferative diseases. Brit J Haematol 1989; 72:530-533.
22. Willman CL. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance Brit J Cancer 1994; 70 (supp XXIII): S29-S33.
23. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994, 343:767-768.
24. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL.Duncan MH, Guilliland DG. Langerhans'-cell histiocytosis (histiocytosts X): a clonal proliferative disease. N Engl J Med 1994; 331:154-160.
25. 50 (4 p.).
26. Galli SJ New concepts about the mast cell. N Eng J Med 1993; 328.257-263.
27. Wasserman SI. Mast cell biology J Allergy Clin Immunol 1990; 86:590-593.
28. Kitamura Y, Kasugal T, Anzono N, Matsuda H Development of mast cells and basophils processes and regulation mechanisms. Am J Med Sci 1993;306:185-191.
29. 6 anemic mice Blood 1979; 53:492-497.
30. Kitamura Y, Go S. Decrease of mast cells in W/W mice and their increase by bone marrow transplantation. Blood 1978; 52 447-452.
31. Denburg JA, Richardson M, Telizyn S. Bienenstock J Basophil/mast cell precursors in human peripheral blood. Blood 1983; 61: 775-781.
32. Sonoda T, Kitamura Y, Haku Y, Mon KJ. Mast-cell precursors in various haematopoietic colonies of mice produced in vivo and in vitro. Br J Haematol 1983; 53 611-620
33. Denburg JA, Telizyn S, Messner H, Jamal BLN, Ackerman SJ, Gleich GJ, Bienenstock J. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 1985, 66.312-316.
34. Escribano Mora L. Ontogenia y diferenciación del mastocito. Med Clin (Barc) 1988; 91:739-740.
35. Webb TA, Li C-Y, Yam LT Systemic mast cell disease A clinical and hemathopatologic study of 26 cases. Cancer 1982; 49:927-938.
36. Tharp MD. The spectrum of mastocytosis. Am J Med Sci 1985; 289:119-132
37. Travis WD, Li C-Y, Hoagland HC, Travis LB, Banks PM, Mast cell leukemia: report of a case and review of the literature. Mayo Clinic Proc 1986; 61:957-966.
38. Travis WD, Li C-Y, Bergstralh MS, Yam LT, Swee RG. Systemic mast cell disease:analysis of 58 cases. Medicine 1988, 67:345-368
39. Lortholary O, Casassus P, Laroche L, Lortholary P, Diebold J. Mastocytoses systsmiques et nastocytoses malignes. La Presse Medicale 1990; 19:125-128.
40. Austen KF. Systemic mastocytosis N Engl J Med 1992; 326 639-640.
41. Gennes Ch, Francés C, Piette JC. Mastocytoses systémiques Encid Med Chir (Paris-France), Hématologie 1993, 13-011-E-50 (7 p.).
42. Travis WD, Li C-Y, Yam LT, Bergstralh MS, Swee RG Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988; 62:965-972.
43. Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous ocurrence of myeloproliferative disorders. Brit J Haematol 1990; 76:186-193.
44. Swolin B, Rödjer S, Roupe G. Cytogenetic studies and in vitro colony growth in patients with mastocytosis. Blood 1987; 70:1.928-1.932.
45. Weller PF The immunobiology of eosinophils. N Engl J Med 1991; 324:1.110-1.117.
46. Diggs LW, Sturn D. Bell A La morfología de las células de la sangre humana. North Chicago Ill., EE UU.: Abbot Laboratories, 1971
47. Chusid MJ, Dale DC, West BC, Wolff SM. The hyppereosinophilic syndrome. Medicine 1975; 54:1-27.
48. Suen K, Burton JD, The spectrum of eosinophilic infiltration of the gastrointestinal tract and its relationship to other disorders of angiitis and granulomatosis. Human Pathol 1979; 10:31-42.
49. Coutant G, Blétry O Pathologie de l'éosinophile. Encycl Méd Chir (Paris-France), Hématologie 1993, 13-009-A-10 (12 p.).
50. Bain BJ. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. Brit J Haematol 1996; 95:2-9.
51. Wainscoat JS, Fey MF. Assessment of clonality in human tumours: a review. Cancer Res 1990; 50 1.355-1.360.
52. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis in creases mutagenesis. Science 1990, 249:970-971.
53. Kurahashi H, Hara J, Yumura-Yagi K. Monoclonal nature of transient abnormal myelopoiesis in Down syndrome. Blood 1991; 77:1.161-1 163
54. Weiss LM, Wood GS, Trela M. Clonal T cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease N Engl J Med 1986; 315:475-479
55. Kyle RA, Lust JA Monoclonal gammopathies of undetermined significance. Sem Hematol 1989; 26:176-200.
56. Berger F, Deleduse HJ Lymphomes non hodgkinienens des transplantés. Encycl Med Chir (Paris-France). Hematologie 1994; 13-016-k-20.